ANAB — AnaptysBio, Inc. stock price, charts and financials

QT71AnaptysBio, Inc.

AnaptysBio, Inc. (NASDAQ: ANAB) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
55.13
+1.47+2.74%
OverviewShort InterestFilings
ANABQT71AnaptysBio, Inc.·NASDAQ
55.13+2.74%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20268-KCurrent report
Jun 29, 2026ARSAnnual report to shareholders
Jun 29, 2026DEFA14AAdditional proxy soliciting materials
Jun 29, 2026DEF 14ADefinitive proxy statement
Jun 22, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 21, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20263Initial statement of beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 13, 20263Initial statement of beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
May 11, 20268-KCurrent report
Apr 29, 20264Statement of changes in beneficial ownership
Apr 28, 202610-K/AAnnual report (amended)
Apr 24, 20268-K/ACurrent report (amended)
Apr 23, 20264/AStatement of changes in beneficial ownership (amended)
Apr 22, 20264Statement of changes in beneficial ownership
Apr 22, 20264Statement of changes in beneficial ownership
#1 / 25 of 331
Page
▼
/ 14